WO2012068372A1 - Method of and system for printing in-well calibration features - Google Patents
Method of and system for printing in-well calibration features Download PDFInfo
- Publication number
- WO2012068372A1 WO2012068372A1 PCT/US2011/061184 US2011061184W WO2012068372A1 WO 2012068372 A1 WO2012068372 A1 WO 2012068372A1 US 2011061184 W US2011061184 W US 2011061184W WO 2012068372 A1 WO2012068372 A1 WO 2012068372A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- feature
- compound
- calibration
- capture
- features
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
- B01L3/5085—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B30/00—Methods of screening libraries
- C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00279—Features relating to reactor vessels
- B01J2219/00306—Reactor vessels in a multiple arrangement
- B01J2219/00313—Reactor vessels in a multiple arrangement the reactor vessels being formed by arrays of wells in blocks
- B01J2219/00315—Microtiter plates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00351—Means for dispensing and evacuation of reagents
- B01J2219/00385—Printing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/0054—Means for coding or tagging the apparatus or the reagents
- B01J2219/00572—Chemical means
- B01J2219/00576—Chemical means fluorophore
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/0068—Means for controlling the apparatus of the process
- B01J2219/00693—Means for quality control
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00725—Peptides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/0074—Biological products
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/14—Process control and prevention of errors
- B01L2200/148—Specific details about calibrations
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/0627—Sensor or part of a sensor is integrated
- B01L2300/0636—Integrated biosensor, microarrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0829—Multi-well plates; Microtitration plates
Definitions
- the present invention relates to preparation of assay substrates, and, more specifically, to methods and systems for printing in- well calibration features onto assay substrates.
- An assay substrate is a surface upon which various chemical and/or biological analyses can be performed.
- Examples of an assay substrate include microarray plates, glass slides, and microtiter plates.
- a microtiter plate is a flat plate that has multiple "wells" formed in its surface. Each well can be used as a small test tube into which various materials can be placed to perform biochemical analyses.
- One illustrative use of microtiter plates includes an enzyme-linked immunosorbent assay (ELISA), which is a modern medical diagnostic testing technique.
- ELISA enzyme-linked immunosorbent assay
- a capture antibody is printed in the bottom of a well in a microtiter plate.
- the capture antibody has specificity for a particular antigen for which the assay is being performed.
- a sample to be analyzed is added to the well containing the capture antibody, and the capture antibody "captures" or immobilizes the antigen contained in the sample.
- a detect antibody is then added to the well, which also binds and/or forms a complex with the antigen. Further materials are then added to the well which cause a detectable signal to be produced by the detect antibody. For example, when light of a specific wavelength is shone upon the well, the antigen/antibody complexes will fluoresce.
- the amount of antigen in the sample can be inferred based on the magnitude of the fluorescence.
- a compound can be added to the well that causes the detect antibody to emit light within a predetermined wavelength (e.g., 400-500 nm). This light can be read by a charged-coupled device (CCD) camera to measure the optical brightness of the emitted light.
- CCD charged-coupled device
- the absorbency, fluorescence, or electrochemical signal of the well can be measured and compared with a standard to more accurately determine the presence and quantity of the sample antigen.
- a calibration feature with a known concentration of antigen can be placed in wells separate from the wells that receive antigen-containing patient samples.
- signal variability such as fluorescence variability, in the different wells can decrease the accuracy of comparing results from separate wells.
- Figures 1 A-B show a cross-sectional side view and a top view, respectively, of two wells in a microtiter plate.
- Figures 2A-C show a series of cross-sectional side views of a well in a microtiter plate during a known method of conducting an ELISA.
- Figure 3 shows a method of preparing in-well calibration features in accordance with some embodiments.
- Figures 4A-C show a series of cross-sectional side views of a well in a microtiter plate during a method of conducting an ELISA in accordance with some embodiments.
- Figure 5 shows a cross-sectional side view of a well in a microtiter plate with a number of printed features in accordance with some embodiments.
- Figure 1 A shows an illustration of a cross-sectional side view of two wells in a microtiter plate 100.
- the well substrate is formed of a polystyrene base 105.
- Other potential substrate materials include, but are not limited to, nitrocellulose, glass, and other plastic materials.
- Figure IB shows an illustration of a top view of two wells in a microtiter plate 100.
- features can have different shapes, such as, for example, a rounded shape.
- the assay substrate can be, for example, a 96-well microtiter plate.
- the features can be, for example, about 300 ⁇ to about 500 ⁇ in diameter.
- Figures 2A-C show a series of cross-sectional side views 200 of a well 205 during a known method of conducting an ELISA. After the capture antibody feature 210 has been printed onto the bottom of the well 205, a blocking material is added to the well to block plate binding sites 215 that remain on the plate 200. This prevents non-selective binding of sample antigens to the base of the well during the ELISA, which would give false readings. Second, an antigen-containing sample is added to the well.
- Figure 2B shows the antigen 220 binding to the capture antibody feature 210.
- Figure 2C shows the enzyme-linked detect antibody 230 binding to the antigen 220.
- the well is then washed so that unbound antibody- enzyme conjugates are removed.
- a substance is applied which converts the enzyme into a detectable signal, such as a color, fluorescent, or electrochemical signal.
- absorbency, fluorescence, or electrochemical signal of the well is measured and compared with a standard to determine the presence and quantity of the sample antigen.
- a standard can be generated by printing calibration features with a known concentration of antigen in wells that are separate from the wells that receive patient samples.
- Figure 4 A shows a cross-sectional side view of one plate well with two capture antibody features 410 and 420 and a calibration feature 430 printed on top of capture antibody feature 420.
- the calibration feature 430 is in the same well as the capture antibody feature 410 that will bind to the antigen-containing sample.
- Figure 3 shows a method 300 of printing in- well calibration features on a microtiter plate in accordance with some embodiments. Method 300 reduces or eliminates the inaccuracy that can result from signal variability and well-to-well variability by printing a calibration feature with a known amount of antigen in the same well as the capture antibody feature that binds to antigen-containing samples. Not only does method 300 reduce the variance of assay results, it also increases throughput, as all the wells of a plate can be used to analyze patient samples.
- Suitable samples include proteomic samples such as, for example, from cell lysates, cell supernatants, plasma, serum, or other biological fluids.
- a "target plate” is a plate that is to be prepared (e.g., printed, blocked, and processed for later usage) for a particular set of analyses.
- a "source plate” is a plate that has a supply of the material to be printed onto a target plate.
- the wells of a source plate can be filled with various types of antibodies that are to be printed onto target plates.
- the source plate is prepared for the printing process (step 310). This can include filling the wells of the source plate with the desired material to be printed onto the target plate.
- the target plate is prepared for printing (step 320). This can include washing and/or performing other surface treatments to enable the material to be printed to properly adhere to the bottom surface of the plate well.
- the source and target plates are then fit into a printing apparatus (e.g., a 2470 Arrayer available from Aushon Biosystems, Inc. of Billerica, MA) (step 330).
- Capture antibody features are printed in the wells of the target plate (step 340).
- calibration features with a known concentration of an antigen are precisely printed onto the capture antibody features (step 350).
- the known concentration of an antigen ranges from the order of femtogram (10 15 g) per milliliter to milligram (10 3 g) per milliliter.
- Implementations of the invention using the 2470 Arrayer can achieve precise printing of the calibration features onto the capture antibody features, such that the positional misalignment between an outer edge of the calibration features and an outer edge of the capture antibody features is about 4 ⁇ or less.
- Other implementations of the invention can tolerate positional misalignments between an outer edge of the calibration features and an outer edge of the capture antibody features of greater than about 4 ⁇ , depending on the size of the features. For example, when printing features are in the range of about 120 ⁇ to about 240 ⁇ in diameter, positional misalignment between an outer edge of the calibration features and an outer edge of the capture antibody features of about 10 ⁇ can be tolerated.
- Figure 4A shows a cross-sectional side view of one plate well with two capture antibody features 410 and 420 and a calibration feature 430 printed on top of capture antibody feature 420.
- the calibration feature 430 is in the same well as the capture antibody feature 410 that will bind to the antigen-containing sample.
- the printed target plate is incubated for a period of time (step 360), and a blocking material, which does not react to the capture antibody, is applied to the target plate using known methods (step 370).
- the blocking material adsorbs to the remaining binding surfaces of the plate and binds to antigens of non-specific interaction, thus reducing background signal.
- the printed target plate is then dried (step 380).
- a blocking material solution is applied to the surfaces of the bottoms of a plurality of wells in a microtiter plate via a spraying process, as described in U.S. Provisional Patent Application 61/372,552 entitled Method of and System for Applying Blocking Material to Assay Substrates, filed on
- an airbrush e.g., a Paasche Talon model TG0210
- TG0210 a Paasche Talon model TG0210
- the blocking material is propelled by a compressed air source, e.g., a standard air compressor that supplies clean and dry air, at a pressure of about 138 kPa (20 psig).
- the flow rate of the airbrush is set to about 10 ml/min.
- the application of the blocking material reduces or eliminates malformation and/or toppling of features during the addition of blocking material to the microtiter wells.
- the plates prepared according to the spraying process discussed herein have superior feature uniformity
- the nozzle of the airbrush is positioned about 15 cm (6 inches) from the surface of the plate, and the airbrush is swept across the entire surface while keeping the nozzle perpendicular to the surface of the plate.
- the center of the spray pattern is essentially normal to the surface of the plate.
- the spraying is continued at least until the level of blocking material in the well covers the printed features 530. After that level of blocking material is achieved, additional blocking material can be added by continuing the spraying process, or, optionally, additional blocking material can be added via micropipette, as described herein.
- the blocking can be applied by-hand.
- the blocking can be applied by automated machinery.
- the plate can be placed on a conveyor over which is mounted one or more spray nozzles.
- the rate of the conveyor is controlled to ensure adequate residence time of the plates within the spray pattern of the one or more nozzles. For example, if the total flow rate of all of the nozzles is about 10 ml/min, the conveyor speed can be controlled to provide that at least some portion of the surface of the plate is under the spray pattern for 1 minute.
- the plate can be held is a fixed position and an automated arm can direct one or more spray nozzles above the surface of the plate.
- the blocking material flow rate can vary between 5-20 ml/min
- the distance between the airbrush flow nozzle and the surface of the plate can vary between 2-41 cm (1-16 inches)
- the air pressure can vary between 34-207 kPa (5-30 psig). It is understood that these ranges are merely illustrative and are not intended to be limiting.
- the target plate is then processed for usage or storage using known methods (step 390). For example, the target plate can be incubated at about 4°C overnight.
- excess blocking material e.g., the blocking material that has not bound to the bottom of the well
- excess blocking material can be removed from the target plate, the plate can then be dried, and then the plate can be placed into a moisture -resistant package for storage.
- the disclosed method of printing in-well calibration features reduces or eliminates inaccuracy that can result from having the calibration feature printed in a separate well from the capture antibody feature that will bind to the antigen- containing sample.
- the disclosed method also increases throughput, as all the wells of a plate can be used to analyze patient samples.
- FIG. 4B shows a cross-sectional side view of the well after an antigen-containing sample has been added, and patient antigen 440 binds to the capture antibody 410.
- enzyme-linked detect antibodies are added to the well.
- Figure 4C shows the enzyme-linked detect antibody 450 binding to the antigen 440 and calibration feature 430.
- a substance, such as a chemiluminescent substrate solution, is applied to convert the enzyme into a detectable signal.
- the signals are measured, and the presence and quantity of the sample antigen is determined using methods known in the art.
- two or more capture antibody features can be printed on each well, and one or more calibration features of varying antigen concentrations can be printed on each well.
- Figure 5 shows a cross-sectional side view of one plate well with capture antibody features 510 and 520 printed at the bottom of the well 505.
- Five calibration features 530 with varying concentrations of antigen are precisely printed on top of capture antibody features 520.
- the series of calibration features with varying concentrations of antigen can be used to generate a standard curve. With the varying concentrations of the calibration features being known, the features produce detectable signals of varying intensity related to the known concentrations.
- the standard curve can be compared to the signal of the capture antibody feature binding to the antigen-containing test sample to determine the presence and quantity of the sample antigen.
- the disclosed method reduces or eliminates inaccuracy that can result from having the series of calibration features printed in separate wells from the capture antibody feature that will bind to the antigen-containing sample. It also results in increased throughput and efficiency of assays and other analyses.
- Kits can be made that incorporate the above devices along with any combination of related equipment or reagents, such as reporter reagents or software for reading results of the assay.
- the embodiments described above can be used to detect the presence of antigens and proteins in a patient, such as a patient having an autoimmune disease, antibodies to viral diseases, antibodies to bacterial diseases, antibodies to allergic reactions, or antibodies to cancers.
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020137015223A KR20140063499A (en) | 2010-11-17 | 2011-11-17 | Method of and system for printing in-well calibration features |
CA2818483A CA2818483C (en) | 2010-11-17 | 2011-11-17 | Method of and system for printing in-well calibration features |
JP2013540013A JP6203638B2 (en) | 2010-11-17 | 2011-11-17 | Method and system for printing an in-well calibration mechanism |
EP11840749.3A EP2640876B1 (en) | 2010-11-17 | 2011-11-17 | Method for printing in-well calibration features |
US13/630,917 US20130266969A1 (en) | 2010-11-17 | 2012-09-28 | Method of and system for printing in-well calibration features |
US15/852,939 US20180120310A1 (en) | 2010-11-17 | 2017-12-22 | Method of and System for Printing In-Well Calibration Features |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41466310P | 2010-11-17 | 2010-11-17 | |
US61/414,663 | 2010-11-17 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/630,917 Continuation US20130266969A1 (en) | 2010-11-17 | 2012-09-28 | Method of and system for printing in-well calibration features |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2012068372A1 true WO2012068372A1 (en) | 2012-05-24 |
Family
ID=46084414
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2011/061184 WO2012068372A1 (en) | 2010-11-17 | 2011-11-17 | Method of and system for printing in-well calibration features |
Country Status (6)
Country | Link |
---|---|
US (2) | US20130266969A1 (en) |
EP (1) | EP2640876B1 (en) |
JP (1) | JP6203638B2 (en) |
KR (1) | KR20140063499A (en) |
CA (1) | CA2818483C (en) |
WO (1) | WO2012068372A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013074643A2 (en) | 2011-11-14 | 2013-05-23 | Aushon Biosystems, Inc. | Systems and methods to enhance consistency of assay performance |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0913258D0 (en) | 2009-07-29 | 2009-09-02 | Dynex Technologies Inc | Reagent dispenser |
US9523701B2 (en) | 2009-07-29 | 2016-12-20 | Dynex Technologies, Inc. | Sample plate systems and methods |
US10562032B2 (en) | 2017-05-26 | 2020-02-18 | Aushon Biosystems, Inc. | Systems and methods for automatic plate washing |
US11686730B2 (en) | 2020-04-30 | 2023-06-27 | Quanterix Corporation | Quantitative antibody test |
GB202010627D0 (en) | 2020-07-10 | 2020-08-26 | Qbd (Qs-Ip) Ltd | Blocking method |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030198967A1 (en) | 2002-04-23 | 2003-10-23 | Matson Robert S. | Multi-functional microarrays and methods |
US20040049351A1 (en) * | 2002-08-28 | 2004-03-11 | Matson Robert S. | Immunosorbent assay in microarray format |
US20070259366A1 (en) * | 2006-05-03 | 2007-11-08 | Greg Lawrence | Direct printing of patterned hydrophobic wells |
US20080032281A1 (en) * | 2004-06-01 | 2008-02-07 | Umedik Inc. | Method and Device for Rapid Detection and Quantitation of Macro and Micro Matrices |
US20100075864A1 (en) * | 2006-07-14 | 2010-03-25 | Prechl Jozsef | Measurement of complement activation products on antigen arrays |
US20100093557A1 (en) * | 2006-11-28 | 2010-04-15 | Pictor Limited | Assay Membrane and Method of Use Thereof |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5395754A (en) * | 1992-07-31 | 1995-03-07 | Hybritech Incorporated | Membrane-based immunoassay method |
AU2002305337A1 (en) * | 2001-05-03 | 2002-11-18 | Genometrix Genomics, Inc. | Method and apparatus to determine the performance of protein arrays |
US20040121334A1 (en) * | 2002-12-19 | 2004-06-24 | Kimberly-Clark Worldwide, Inc. | Self-calibrated flow-through assay devices |
US20040229226A1 (en) * | 2003-05-16 | 2004-11-18 | Reddy M. Parameswara | Reducing microarray variation with internal reference spots |
GB0311902D0 (en) * | 2003-05-22 | 2003-06-25 | Cambridge Life Sciences | Assay method and apparatus |
FR2864550B1 (en) * | 2003-12-29 | 2006-02-24 | Commissariat Energie Atomique | CHIP OF ANALYSIS WITH STANDARD RANGE, KITS AND METHODS OF ANALYSIS. |
CA2475456A1 (en) * | 2004-07-20 | 2006-01-20 | Biophys, Inc. | Method and device to optimize analyte and antibody substrate binding by least energy adsorption |
US20060292586A1 (en) * | 2004-12-17 | 2006-12-28 | Schroth Gary P | ID-tag complexes, arrays, and methods of use thereof |
US20060141527A1 (en) * | 2004-12-29 | 2006-06-29 | Caracci Stephen J | Method for creating a reference region and a sample region on a biosensor and the resulting biosensor |
WO2007048436A1 (en) * | 2005-10-29 | 2007-05-03 | Bayer Technology Services Gmbh | Process for determining one or more analytes in samples of biological origin having complex composition, and use thereof |
FR2894596B1 (en) * | 2005-12-13 | 2012-08-10 | Centre Nat Rech Scient | PROCESS FOR AUTOCALIBRATION OF BIOPUCES |
CA2647953A1 (en) * | 2008-12-29 | 2010-06-29 | Sqi Diagnostics Systems Inc. | Multiplex analyte detection |
-
2011
- 2011-11-17 WO PCT/US2011/061184 patent/WO2012068372A1/en active Application Filing
- 2011-11-17 CA CA2818483A patent/CA2818483C/en active Active
- 2011-11-17 KR KR1020137015223A patent/KR20140063499A/en not_active Application Discontinuation
- 2011-11-17 JP JP2013540013A patent/JP6203638B2/en not_active Expired - Fee Related
- 2011-11-17 EP EP11840749.3A patent/EP2640876B1/en active Active
-
2012
- 2012-09-28 US US13/630,917 patent/US20130266969A1/en not_active Abandoned
-
2017
- 2017-12-22 US US15/852,939 patent/US20180120310A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030198967A1 (en) | 2002-04-23 | 2003-10-23 | Matson Robert S. | Multi-functional microarrays and methods |
US20040049351A1 (en) * | 2002-08-28 | 2004-03-11 | Matson Robert S. | Immunosorbent assay in microarray format |
US20080032281A1 (en) * | 2004-06-01 | 2008-02-07 | Umedik Inc. | Method and Device for Rapid Detection and Quantitation of Macro and Micro Matrices |
US20070259366A1 (en) * | 2006-05-03 | 2007-11-08 | Greg Lawrence | Direct printing of patterned hydrophobic wells |
US20100075864A1 (en) * | 2006-07-14 | 2010-03-25 | Prechl Jozsef | Measurement of complement activation products on antigen arrays |
US20100093557A1 (en) * | 2006-11-28 | 2010-04-15 | Pictor Limited | Assay Membrane and Method of Use Thereof |
Non-Patent Citations (1)
Title |
---|
See also references of EP2640876A4 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013074643A2 (en) | 2011-11-14 | 2013-05-23 | Aushon Biosystems, Inc. | Systems and methods to enhance consistency of assay performance |
EP2780112A4 (en) * | 2011-11-14 | 2016-06-22 | Aushon Biosystems Inc | Systems and methods to enhance consistency of assay performance |
US11130136B2 (en) | 2011-11-14 | 2021-09-28 | Aushon Biosystems, Inc. | Systems and methods to enhance consistency of assay performance |
Also Published As
Publication number | Publication date |
---|---|
CA2818483A1 (en) | 2012-05-24 |
US20130266969A1 (en) | 2013-10-10 |
EP2640876A1 (en) | 2013-09-25 |
US20180120310A1 (en) | 2018-05-03 |
CA2818483C (en) | 2020-12-15 |
EP2640876A4 (en) | 2014-04-16 |
JP2013543981A (en) | 2013-12-09 |
EP2640876B1 (en) | 2017-03-01 |
KR20140063499A (en) | 2014-05-27 |
JP6203638B2 (en) | 2017-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20180120310A1 (en) | Method of and System for Printing In-Well Calibration Features | |
US20220048025A1 (en) | Systems and methods to enhance consistency of assay performance | |
JP2009529658A5 (en) | ||
JP2010534831A (en) | Fine channel type sensor composite structure | |
US10191037B2 (en) | Methods of and systems for improved detection sensitivity of assays | |
JP2013543981A5 (en) | ||
JP4253695B2 (en) | Substance determination method and substance determination device | |
EP1512012B1 (en) | Biomolecular kinetics method using a flow-through microarray | |
DK2603325T3 (en) | METHOD AND SYSTEM FOR APPLICATION OF BLOCKING MATERIAL ON sample substrates | |
WO2018154814A1 (en) | Biomaterial immobilizing method and uses thereof | |
JP4920173B2 (en) | Calibration microarray |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11840749 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2013540013 Country of ref document: JP Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2818483 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REEP | Request for entry into the european phase |
Ref document number: 2011840749 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011840749 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 20137015223 Country of ref document: KR Kind code of ref document: A |